Radiotracers could improve choice of bladder cancer therapies

A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...
News-Medical.Net on MSN

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
FierceBiotech

Roche receives FDA breakthrough label for AI-powered lung cancer companion diagnostic test

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial-intelligence-powered analysis to provide what the company says could become ...
Science Daily

Scientists uncover a hidden switch that helps cancer cells thrive

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...
Medindia

Can We Predict Bone Marrow Cancer Relapse Early?

New immune roadmaps help physicians detect cancer recurrence early and customize treatments to the body’s defenses, providing ...
TMCnet

Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials

The Phase 1b/2 SCLC trial and Phase 2 VIRO-25 trial are actively enrolling in dose escalation cohorts with an aim to optimize efficacy, safety, and tolerability of Olvi-Vec. The trials are being ...